| Ytd | 41.08% | |
| 1y | 53.03% |
| Open | 53.14 | Prev Close | 52.84 | Low | 52.44 | High | 55.89 | Mkt Cap | 2.84B |
| Vol | 712.51K | Avg Vol | 1.08M | EPS | 0.21 | P/E | 265.76 | Forward P/E | 128.60 |
| Beta | 1.25 | Short Ratio | 4.48 | Inst. Own | 105.85% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 10-27 | 50-d Avg | 50.37 | 200-d Avg | 36.60 | 1yr Est | 54.89 |
Analysts raised targets for ACN, SYNA, ATRC and MPC; cut targets for CSX, NKE, MKC and FHTX, with AT
Analysts downgraded FHTX, BUSE, ASTS, ATRC and EQBK; targets fell for BUSE, ASTS and EQBK but rose f
Freedom Capital Markets analyst Keith Hinton downgrades AtriCure (NASDAQ:ATRC) from Buy to Hold a